IGF-1 LR3

🧬 IGF-1 LR3 — 0.1mg & 1mg

Recombinant Peptide Analog | ≥99% HPLC Verified | Laboratory Grade

Compound Overview

IGF-1 LR3 is a recombinant peptide analog supplied for laboratory and analytical research use. It contains structural modifications relative to native insulin-like growth factor-1 and is utilized in controlled experimental environments for receptor interaction and peptide signaling studies.

SPEC supplies IGF-1 LR3 in 0.1mg and 1mg formats, allowing researchers to select the appropriate quantity for structured in vitro investigations.

Each batch undergoes analytical verification to confirm identity, structural integrity, and purity prior to release.

Research Context

IGF-1 LR3 is utilized in controlled laboratory environments for:

• Receptor-binding investigations
• Peptide analog characterization
• Signal cascade analysis
• Structure–function research
• In vitro assay development

Its engineered structure allows examination of regulated receptor-mediated signaling dynamics in experimental models.

No clinical or therapeutic application is intended or implied.

Manufacturing & Quality Control

Each SPEC IGF-1 LR3 batch undergoes:

• High-Performance Liquid Chromatography (HPLC) purity verification
• Mass spectrometry identity confirmation
• Controlled lyophilization process
• Visual inspection for consistency
• Batch-level documentation prior to release

SPEC follows a specification-driven release protocol to ensure reproducibility and analytical reliability.

⚠ Research Use Disclaimer

This product is intended strictly for laboratory research use only. Not for human consumption. Not for medical, diagnostic, or therapeutic use. Purchaser assumes responsibility for compliance with applicable regulations.